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PENENTUAN FORENSIK TERHADAP TABLET DADAH DENGAN 
PENDEDAHAN LUARAN  
 
ABSTRAK 
Tablet farmaseutikal adalah sejenis dos preskripsi yang merangkumi komponen aktif 
bahan ubat dengan bahan cair yang sesuai. Pendedahan ubat terhadap faktor 
persekitaran, seperti kelembapan, panas dan tekanan, berkemungkinan boleh 
merosakkan produk serta mengubah sifat fizikokimia ubat. Perubahan tersebut boleh 
mempengaruhi keselamatan dan keberkesanan ubat tersebut. Kajian ini bertujuan 
untuk menyiasat kesan pendedahan persekitaran pada ubat berbentuk tablet. Dalam 
kajian ini, sampel didedahkan dengan keadaan dan pencemaran yang berbeza termasuk 
tertutup, suhu, air, asid, bes dan minyak. Kemudian, sampel tersebut didedahkan 
selama satu minggu dan satu bulan dalam keadaan yang ditetapkan. Setelah tamat 
tempoh pendedahan, pemeriksaan fizikal dilakukan untuk memeriksa perubahan 
fizikal yang berlaku pada tablet. Profil sampel telah dihasilkan melalui analisis 
spektroskopi inframerah  transformasian Fourier (ATR-FTIR). Data ATR-FTIR juga 
dianalisis dengan Analisis Komponen Utama (PCA) untuk membezakan sampel tablet 
ubat berdasarkan pendedahan persekitaran. Walaupun didedahkan kepada faktor 
persekitaran, kesemua profil ATR-FTIR kelihatan sangat serupa antara sampel kerana 
parasetamol adalah ramuan utama tablet. Oleh sebab PCA tidak menunjukkan 
pembezaan bererti dengan pendedahan persekitaran yang berbeza, Analisis 
Diskriminasi (DA) telah dilakukan untuk mewujudkan visualisasi dan pembezaan 
yang lebih baik antara sampel dalam kumpulan. Keputusan dari DA menunjukan 
bahawa Panadol Kanak-kanak dan Panadol Larut telah mencapai 100% pemilikan 




yang tepat. Sampel lain termasuk Paracil (SM), Paracil (Mal), Panadol Menstrual, 
Uphamol-650 dan Febricol-RX sukar untuk dibezakan. Kesimpulannya, pemerhatian 
fizikal lebih sesuai dalam membezakan dadah berbentuk tablet berbanding dengan 
analisis kimia. Pendedahan luar dinampakkan tidak mengenakan sebarang kesan 









Pharmaceutical tablet is a prescription dosage type that includes the active componen
t of the medication material with the suitable diluents. Exposure of drugs to 
environmental factors, such as moisture, heat and stress, might deteriorate the product 
as well as change the physicochemical properties of the drug. Such changes might also 
influence the safety and effectiveness of the medication tablet. This study was aimed 
to investigate the effect of environmental exposure on drug tablets. In this study, the 
samples were insulted with different condition and contaminants including closed, 
temperature, water, acid, base and oil. The samples were then exposed for the duration 
one week and one month. After the exposure duration end, physical examination was 
conducted to examine the physical changes that occur to the tablets. Samples profiles 
were generated through attenuated total reflectance-Fourier transform infrared 
spectroscopy (ATR-FTIR) analysis. The ATR-FTIR data was also decomposed by 
Principal Component Analysis (PCA) to distinguish the drug tablet samples based on 
the environmental exposures. Although subjected to environmental exposures, the 
ATR-FTIR profiles appeared very similar among the samples, as paracetamol is the 
main ingredient of the tablet. Since PCA did not showed significant discrimination 
with different environmental exposure, Discrimination Analysis (DA) was conducted 
to create better visualization and differentiation among the samples. DA results 
demonstrated that Panadol for Children and Panadol Soluble had achieved 100% 




classification. Other samples including Paracil (SM), Paracil (Mal), Panadol 
Menstrual, Uphamol-650 and Febricol-RX were hardly to be distinguished. In 
conclusion, physical observation was more suited in discrimination of tableted drug as 
compared to chemical analysis. External insults were found not to introduce any 

















1.1. Drug Tablet  
Drug tablet is a pharmaceutical dosage in solid form containing active ingredient of 
drug substance with appropriate diluents (Bhowmik, 2014; Lanjewar et al., 2017). 
Drug tablet is usually produced by compression or moulding method. Compressed 
tablet is produced by large scale production method while moulded tablet is produced 
by small-scale operation. Tablets continue to be the most preferred dosage form 
because of the benefit the tablet give towards the manufacturer and patient. Tablet type 
drug provides better protection to the drug from external temperature, humidity, 
oxygen, light and stress during transportation. In addition, tablet also ensures accurate 
of dosage, compactness, portability, softness of taste and ease of use  (Bhowmik, 
2014).  
 
Drug tablets can be divided into several types that are compressed, moulded or 
triturated, dispensing and hypodermic. Compressed tablet is formed by compression 
of powdered, crystalline or granular active material either alone or in combination with 
few excipients such as binders, disintegrate agents, sustained-release polymers, 
lubricants, diluents, flavourings and colourants (Bhowmik, 2014; Pharmapproach, 
2017a). Compressed tablets can be in uncoated or coated form (Pharmapproach, 
2017a). Moulded tablet is made from moist material using a mould that gives the shape 




soluble. Dispensing tablet is a tablet that is intended to be added to a given volume of 
water in order to produce a solution for a given concentration of drugs (Bhowmik, 
2014). Yet, this tablet is no longer in use due to its potential of being inadvertently 
distributed to the patient. Hypodermic tablet consists of one or more drugs with easily 
water-soluble ingredients; however, this drug is also no longer used due to the 
difficulty of achieving sterility  (Pharmapproach, 2017a).  
 
1.1.1 Tablet Preparation  
As mentioned in previous section, drug tablets are made by compressing powdered 
drugs with different excipients using a tablet press. Several granulation methods have 
been used to produce a final powder blend in tablet, including direct compression 
method, wet granulation, and dry granulation or roller compaction (Jacques and 
Alexandridis, 2019; Techceuticals, 2015). The method was chosen on the basis of the 
ingredients possessing individual characteristics, such as flow properties and 
compressibility. The appropriate method requires a thorough investigation of each 
ingredient suggested in the tablet for a comprehensive approach (Bhowmik, 2014).  
 
Direct compression is a process of compressing tablet directly from powdered material 
without altering the physical nature of the material. Generally, direct compression is 
selected for crystalline material with good physical properties such as flow property 
and compressibility (Bhowmik, 2014). The substances of the drug are ground and 
mixed with the excipients such as lubricants and disintegrate agents. Grinding and 
mixing are crucial processes, especially when the splitting tablets are produced using 




homogenous mixture. If there is absence of granulation step, the appropriate excipients 
of comparable structure, morphology and particle size must be chosen. The uneven 
distribution of granule particle sizes and different granule shapes can lead to granule 
segregation within the compressed tablet (Jacques and Alexandridis, 2019).  
 
Wet granulation is the most widely used method for tablet preparation because this 
method fulfils all requirements for a good tablet formation although it involves several 
steps and time-consuming. This method involves bounding the powder with a suitable 
binder by adhesion. The binder is diluted with the suitable solvent before being added 
to the blended powder to form wet granules, and then left to form dried granules. 
Surface tension and capillary pressure are important factors for the formation of the 
initial granules. Apart from that, the controlled processing parameter is also crucial 
which could affect the properties of the tablet as well as tablet partitioning (Bhowmik, 
2014; Jacques and Alexandridis, 2019).  
 
Dry granulation or roller compaction is used to form granules without using liquid 
solution. This method is used when the product is sensitive to moisture and cannot 
withstand high temperatures. Compacting and densifying powder is required when 
moisture cannot be used (Bhowmik, 2014). The coherent properties of the substance 
is important when roller compaction is applied. Roller compaction is used to release 
the air trapped and create dense compact material. Excipient with similar structure and 
comparable particle size should also be used to prevent segregation during 
compression of the tablet. Other than that, excipients with good compressibility factor 




(Jacques and Alexandridis, 2019). Figure 1.1 illustrates the granulation method used 
in drug tablet preparation.  
 
Figure 1.1: Granulation method used in drug tablet preparation (Nitin Kadam, 2010) 
 
1.1.2 Tablet Ingredient  
A drug in tablet form contains not only active substance but also various other 
materials known as excipients. Excipient is the additive substances used in the 
formulation of the tablet to enhance the durability, disintegration, bulkiness, 
dissolution rate and bioavailability of the drug (Chaudhari and Patil, 2012; 
Techceuticals, 2015; Varma, 2016). The formulator must carefully and critically 
evaluate the combination of the drug in order to ensure that there is no excipient 
interference with the utilisation of the drug. Excipients that are used in tablet 




colouring agent, flavouring agent and sweetener (Chan and Chew, 2002; Chaudhari 





Table 1.1: Purpose and example of excipient (Chan and Chew, 2002; Chaudhari and 
Patil, 2012; Varma, 2016). 
Excipient  Purpose  Examples  
Diluent Filler that acts as a bulking agent or 
filling material of the drug when the 
drug dosage is insufficient to produce 
the volume 
Sugars, lactose, sucrose, 
sorbitol, inorganic salts 
and polysaccharides i.e.  
primarily microcrystalline 
cellulose 
Binder Used as a binding agent, provides 
consistency and holds the powder 
together to form granules 
Gelatin, glucose, lactose, 
cellulose derivatives, 
starch and Acacia 
Disintegrate 
agent 
Used to facilitate the disintegration or 
break down of a tablet when in contact 
with water in the gastrointestinal tract 
Starch, clays, cellulose, 
cross-linked polymer and 
modified starch such as 
Primogel and Explotab 
Lubricant Used to reduce the friction between the 
die wall and tablet during compression 
and ejection of the tabletting process 
Talc, stearic acid, 
magnesium stearate, 
calcium stearate, 
polyethylene glycol and 
paraffin 
Glidants Used to improve the flow of granules or 
mixture of powders by minimizing the 
friction between particles 
Colloidal, silicon dioxide, 
Asbestos free starch, corn 
starch, fine silica, 







Added to impart aesthetic appearance 
of drugs, provide product identification 













1.2 Problem Statement  
Drug tablet must guaranteed for their reliable and reproducible quality during 
production and storage. Manufacturers are expected to test drugs during and after 
manufacturing to ensure the quality of the drug. With the achievement of desired 
quality, it could ensure the products are suitable for intended uses and not exposing 
the consumer to any risk. Although the drug had followed the standard requirement 
during manufacturing, the inability to keep them in good storage condition from 
manufacturing until dispensing to consumer may expose the drug to different external 
conditions. Even if so, the exposure of drug to the environmental condition such as 
humidity, heat and stress, or external chemical activity such as acid and base, may 
deteriorate the drug or change the physicochemical properties of the drug. 
Physicochemical properties of a drug is crucial to the stability, solubility, membrane 
permeability and drug affinity towards different tissue component in the body (Buba, 
2016).   
 
Besides, activities of smuggling and trafficking could also introduce extra pressure or 
insult to the drugs when transporting them from one place to another. Introduction of 
pressure and insult to the drug might deteriorate or change the safety and quality of the 
drug. The unsafety and poor quality of drug may cause varying effect to the users. 
Other than that, drugs collected from the crime scene must be carefully and properly 
handled and stored to prevent any changes or deterioration to the drug. Failure to 
handle and store the forensic evidence properly and appropriately may expose them to 
various external condition that may cause interference during the drug analysis. The 
interfered results may produce inconclusive result or inadmissibility of evidence to the 




upon external exposure with the aim to gain information regarding the effect of drug 
tablets when exposed to varying exposure including temperature, water, acid, base, 
and oil contamination. 
 
1.3 Aim and Objectives 
The aim of this study is to determine drug tablets upon external exposures using 
Attenuated Total Reflectance-Fourier Transform Infrared (ATR-FTIR) Spectroscopy. 
In order to achieve the aim, the objectives of this study are as follows:  
1. To determine the physical features on the drug tablet packaging material by 
physical examination.    
2. To investigate the effect of external environmental exposure towards the 
physical characteristics of drug tablets.  
3. To analyse the chemical profiles of drug tablets upon external exposure using 
ATR-FTIR spectroscopy.  
 
1.4 Significance of Study   
The determination of drug tablets upon varying external exposure could provide 
important information to the investigators. Theoretically, exposure to the external 
condition such as temperature, water, acid, base and oil would affect the physical 
condition of the drug tablets as well as its stability and effectiveness. Other than that, 
exposure of the drug to the environment might have modified or deteriorate certain 
chemical composition of the drug, leading to possible interference during the drug 
analysis. Hence, the result might be inconclusive or not admissible to the court of law. 




handling, storing or transporting which could potentially exposed the forensic 
evidence to different external condition, and minimising the potential of further 





 CHAPTER 2  
LITERATURE REVIEW 
 
2.0 Illicit Drug Problem 
Illicit drug problem is always a global threat to the world population. According to the 
United Nation Office of Drugs and Crime (UNODC), the number of drug abusers aged 
15 to 64 is estimated to have achieved 271 million people, at approximately 5.5% of 
the world population in 2017. The figure is expected to have increased in more recent 
years. In 2009, the prevalence of drug abusers was relatively lower at 4.8% and 
reaching approximately 5.5% as stated above. Although the prevalence of drug users 
was said to be stable for the past many years, its number had been increasing 
continuously as reflected by the global population growth (Vereinte Nationen and 
Büro für Drogenkontrolle und Verbrechensbekämpfung, 2019). Data showed higher 
prevalence use of opioid in countries such as Africa, Asia, Europe, North America, 
while the use of cannabis was highly reported in North America, South America and 
Asia regions. Over the past decade, there has been diversity of substances available in 
illicit drug market including plant-based substances and synthetic drugs. The 
expansion of  potent drugs, non-medical prescription medicines and potential 
combinations of substance had causes greater and endless risk to the world  (Vereinte 
Nationen and Büro für Drogenkontrolle und Verbrechensbekämpfung, 2019).  
 
Drugs related crimes involve the manufacturing or cultivating, smuggling, trafficking, 
distribution, possession, sale, and lastly the abuse of illicit drugs. Before existing in 




plant or synthesised from chemicals, and subsequently processed in the clandestine 
laboratories. They are frequently cut or adulterated with other substances before their 
distribution to the users to increase to sale bulk and to maximise the income. To reach 
to the users, these illegal drugs must be smuggled or trafficked through involuntary 
conveyance by means of carrying, mailing, making use of human or animals to carry, 
or by other means of transporting from one place to another. Upon reaching into a 
country or a targeted place, these drugs will be packaged, re-distributed and delivered 
to the drug abusers or criminals. In fact, the trading of illegal drugs frequently involves 
multiple layers of individuals throughout a series of activities (United Nations Office 
on Drugs and Crime, 1995).  
 
Every act involving illicit drugs is always risky, complex and a serious security threat 
to the world population.  Illicit drugs bring varying effects to the users, leading to 
behaviours which may generate violence and other illegal activities. Amongst, 
smuggling and trafficking drug is highly associated with violent crimes (United 
Nations Office on Drugs and Crime, 1995). Furthermore, drug users are more prone to 
commit crimes than non-users (U.S Department of Justice, 1994).  
 
2.1 Smuggling and Trafficking Activities  
Drug smuggling and trafficking are dangerous and risky activities by the criminal 
organisations that can corrupt public officials and destroy the structure of a country. 
Drug smuggling is not a business that can be compared with corporations or formal 
organisations. According to (Antonopoulos and Papanicolaou, 2008), drug smuggling 
is based on the formation of groups containing members known as 'officers' and 




involve actively in the smuggling and trafficking activity also include transporters and 
other specialised groups to support the business. In generally, the structure of drug 
smuggling organisations could have consisted of the office of transport, the office of 
finance, the office of distribution and the office of supply (Antonopoulos and 
Papanicolaou, 2008).  
 
The tackle of illicit drug smuggling and trafficking activities by the law enforcement 
authorities is never ended and continue to be to more challenging. Moreover, such 
activities can be within the boundary of a country in smaller scale, but majority of 
them are transnational in nature. Both the parties, namely the drug syndicates and the 
law enforcement authorities, always compete with each other in which the former 
create ways of manufacturing, processing, smuggling, trafficking, distribution and 
sales to gain more profits while the latter implement more sophisticated procedure and 
detection techniques to counter the problems. Whenever there is a demand for illicit 
drugs by the users, the race between both these parties has no sign of ending.  
 
The punishment imposed on individuals involved in drug smuggling and trafficking 
are different based on the countries. Drug smuggling and trafficking can be sentenced 
to death when caught in some countries, including China, Iran, Saudi Arabia, Vietnam, 
Malaysia, and Singapore. In United States, the penalties to drug smuggling and 
trafficking depend on the quantity of the substance and the number of offences that an 
individual have committed. The first trafficking offence could be punished with at least 
5 years in prison. The sentenced could be increased to minimum 20 years if someone 




had committed a second offence that leads to serious injury, the individual shall be 
punished with mandatory life imprisonment (Patterson and Thomas, 2017).  
 
Although harsh penalties and punishment had been implemented by the authorities, 
due to the possibility to obtain big money when succeed, the drug syndicates are 
deemed worth taking the risks. They find ways to escape the supervision and detection 
by the law enforcement authorities which can be generally divided into personal or 
impersonal activities. Personal smuggling and trafficking activities involve 
transportation of illicit drugs across the border or passed by the detection system in 
person. On the other hand, impersonal activities do not directly involve the drug 
traffickers. Additionally, the smuggling and trafficking activities are also varied 
according to different regions and countries due to the demands of illicit drugs and 
drug policies. All regions in the world had been severely impacted by the drug issues.  
 
2.1.1 East and Southeast Asia 
Drug problem in East and Southeast Asia is a serious issue especially when 
Afghanistan, Myanmar and Laos are the largest producers of illicit opium in the world. 
Besides, increase manufacturing of illicit amphetamine-type stimulants (ATS), 
especially methamphetamine in China and Myanmar has also caused a major concern 
to East and Southeast Asia (Kulsudjarit, 2004; United Nations Office on Drugs and 
Crime, 2018).   
 
2.1.1.1 Methamphetamine  
In the 2000s, there has been a huge transformation in the drug market from opiates to 




methamphetamine had affected countries that were known to be a large market for 
heroin such as China and Malaysia. For the first time in Malaysia, the number of 
methamphetamine user has exceeded the heroin user in 2017 (United Nations Office 
on Drugs and Crime, 2019a).   
 
East and Southeast Asia are the biggest manufacturers of illicit ATS, especially 
methamphetamine, in the world (Kulsudjarit, 2004; McKetin et al., 2008). All the 13 
countries in East and Southeast Asia reported that methamphetamine is their main 
problem in 2018 (United Nations Office on Drugs and Crime, 2019a). Reported by 
United Nations Office on Drugs and Crime (2010), six countries compromises of 
Cambodia, China, Laos, Myanmar, Thailand, and Vietnam use tablet form 
methamphetamine while others use methamphetamine in crystal form (United Nations 
Office on Drugs and Crime, 2012, 2010). Methamphetamine has been supplied to the 
illicit market either through the local clandestine manufactured or trafficking for the 
past several decades (Shukla et al., 2012; United Nations Office on Drugs and Crime, 
2019a).  
 
In 2017, the biggest amount of methamphetamine seizure was reported from this 
region with more than 82 tons of methamphetamine were seized (United Nations 
Office on Drugs and Crime, 2019b). While in 2018, the methamphetamine seized had 
increased substantively reaching nearly 116 tons per year. The increase production of 
methamphetamine in East and Southeast Asia occur due to the decrease in the retail 
price of the drug. Besides, the precursor chemicals for methamphetamine had also 






Both tablet and crystalline form of methamphetamine had continued to increase in East 
and Southeast Asia (United Nations Office on Drugs and Crime, 2019b). UNODC 
reported that seizure of methamphetamine tablet form had continued to increase 
annually. Nearly 450 million of methamphetamine tablets were seized in 2017, making 
up a 40% increase as compared to the previous year. In 2018, an estimated 745 million 
of methamphetamine tablets were seized in East and Southeast Asia (United Nations 
Office on Drugs and Crime, 2019b). From the data reported, more than 515 million of 
methamphetamine tablet were seized in Thailand and the amount seized is 17 times 
more than the combined amount of methamphetamine seized for 10 years by all 
countries in East and Southeast Asia. The surplus of methamphetamine tablets within 
this region might be because of the decrease in the retail price of methamphetamine in 
several countries, including Cambodia, Malaysia, Myanmar and Thailand (United 
Nations Office on Drugs and Crime, 2019a).  
 
The seizure of crystalline form methamphetamine has increased every year over the 
last decade. In 2018, around 48 tons of crystalline methamphetamine was seized in 
East and Southeast Asia. Six Mekong countries consists of Cambodia, China, Laos, 
Myanmar, Thailand and Vietnam contributed a total of 72% of crystalline 
methamphetamine from seizure between 2013 and 2018 (United Nations Office on 
Drugs and Crime, 2019a). In 2017, Thailand reported that almost 91% of analysed 
samples has demonstrated up to 90% purity while China reported 89% purity level was 
detected in majority of seized samples. Other countries such as Brunei Darussalam, 
Cambodia, Indonesia, Malaysia and Vietnam reported high purities between 70% and 





Data on the seizure of methamphetamine by region in Thailand proposed significant 
changes in trafficking pattern of methamphetamine originated from Golden Triangle 
with increase flow of crystalline methamphetamine into Malaysia. In 2018, one-third 
of the entire drug seizure seized in Southern part of Thailand, near to Malaysia were 
crystalline methamphetamine (United Nations Office on Drugs and Crime, 2019a). In 
2015, China and Hong Kong have become the top methamphetamine trafficked to 
Australia. While, in 2017, Thailand and Malaysia have respectively ranked second and 
third for methamphetamine trafficking after the United State (United Nations Office 
on Drugs and Crime, 2019b). Moreover, Laos has been used as the targeted transit 
point for methamphetamine trafficked within and from the regions of East and 
Southeast Asia. From 2016 to 2018, seizure of methamphetamine in tablet form had 
increased substantively 75% along the Laos and Thailand border with approximately 
5.1 million to 21 million tablets (United Nations Office on Drugs and Crime, 2019a).  
 
In 2018, large flows of methamphetamine tablets from Myanmar to Bangladesh were 
reported by the Government of Myanmar with approximately one-third of the drug 
seized in the country. Currently, there have been large scale trafficking of 
methamphetamine in the maritime domain that included Indonesia, Japan, and 
Australia. More than 2.6 tons of crystalline methamphetamine were seized in Riau 
Island of Indonesia. Most drug dealer arrested were Taiwanese people. Over the last 
two decade, Taiwanese people were arrested for methamphetamine trafficking to 
countries such as Australia, Cambodia, Japan, Malaysia, Philippines, Korea and 





Apart from trafficking within the East and Southeast Asia, drug trafficking activities 
outside this region was also on the rise. There has been evidence where 
methamphetamine has been trafficked to Israel from the Mekong region. 
Methamphetamine trafficked to Israel from Laos, Thailand and Vietnam were 
recorded as ten top trafficking routes of methamphetamine in Asia and Pacific in 2017. 
Japan and Korea also reported trafficking of methamphetamine from the outside region 
such as North America and Mexico. Estimated 27 parcel posts containing crystalline 
methamphetamine were seized with 26 of these parcels have been sent from California 
during the first half of 2018 (United Nations Office on Drugs and Crime, 2019a).  
 
Other than the drug itself, the chemical precursor to produce methamphetamine had 
also been detected to be trafficked into the country. In recent years, seizure of 
chemicals such as tert-butyl methyl (1-phenylpropan-2-yl) carbamate (t-BOC) has 
been seized in Australia, Japan, and New Zealand. t-BOC is easily to be converted to 
methamphetamine by treating with sulphuric acid. Besides, ephedrine and 
pseudoephedrine remain as the main chemical precursors to produce 
methamphetamine in China, Australia, and Korea. Nevertheless, there has been a clear 
indication of the extensive use of 1-phenyl-2-propanone to produce methamphetamine 
in Golden Triangle countries. Again, Laos is a targeted transit point for smuggling of 
chemicals used to manufacture methamphetamine with 5 tons of chemicals was seized 
reported in 2018 (United Nations Office on Drugs and Crime, 2019a).  
 
In 2017, 206 tons of 2-bromo-1-phenyl-1-propane has been seized by the Chinese 
authorities. 2-bromo-1-phenyl-1-propane is a chemical that is not under international 




for chemical precursor has become challenging to the country. Besides, sodium 
cyanide which is not listed under international control can also be used to manufacture 
methamphetamine. A huge quantity of sodium cyanide has been seized in Myanmar 
and Thailand since 2016. Still, there is no proof on the utilisation of this chemical 
compound to manufacture methamphetamine in Golden Triangle countries (United 
Nations Office on Drugs and Crime, 2019a).  
 
2.1.1.2 Heroin  
Even though heroin is produced in about 50 countries worldwide, Southwest Asia, 
Southeast Asia and South America are the main regions of illicit poppy cultivation 
(NicDaéid and McKenzie, 2019). Myanmar has become the main producer of opium, 
heroin, and amphetamine-type stimulants (ATS) after Afghanistan. Note that 
Afghanistan is the world largest producer of illicit heroin in Asia (Reid et al., 2006). 
Yong-an (2012) stated that 90% of global illicit opium was produced in Afghanistan 
and Myanmar (Yong-an, 2012). The reported percentage showed that the global 
opiates market has never been eliminated or decreased significantly since 1998 (United 
Nations Office on Drugs and Crime, 2019c). However, there had been a reduced 
amount of opium produced in Myanmar, dropped for approximately 40% from 2013 
to 2018 (United Nations Office on Drugs and Crime, 2019a). This could be due to the 
increase dismantle of heroin clandestine laboratories and seizures of large amount of 
illicit heroin by law enforcement authorities in the past decade (Reid et al., 2006).   
 
The Myanmar-Yunnan-Guangdong route is the most route used to traffic drug into 
Southern China. However, due to the increased law enforcement efforts at the China-




for drug trafficking (Yong-an, 2012). Other than that, an increase of illicit smuggling 
and trafficking of heroin into East and Southeast Asia could also be due to Malaysia 
which had been used as the transit hub to distribute this illicit drug to other Asia 
countries. The border between Thailand and Malaysia in the northern region is the 
possible entry routes used by drug traffickers (Yusoff et al., 2020).  
 
Data from World Customs Organisations revealed that an estimated 70% of heroin 
seizure in China was produced from Myanmar (Yong-an, 2012). While, the World 
Drug Report reported that 11% of the total global quantities of heroin and morphine 
were seized in East and Southeast Asia, excluding the seizure in Afghanistan (United 
Nations Office on Drugs and Crime, 2019c). The total seizure of heroin in Myanmar, 
Thailand and Vietnam had increased as in 2018. Vietnam is the country with the major 
seizure of heroin reported with one third of all illicit heroin seized in East and 
Southeast Asia from 2013 to 2018. Malaysia has also been reported with an increasing 
seizure of heroin being trafficked to this country as an route to the Australia 
(International Narcotics Control Board, 2019a).  
 
2.1.1.3 New Psychoactive Substance (NPS)  
Over a decade, a total of 434 different NPS was seized in East and Southeast Asia. In 
East and Southeast Asia, the most identified NPS is the synthetic cannabinoids 
followed by synthetic cathinones and phenethylamines. Synthetic cannabinoids are not 
only commonly trafficked in East and Southeast Asia but also had contributed the 
largest globally. Japan and Korea were reported with the largest proportion of synthetic 
cannabinoids in East and Southeast Asia region followed by Vietnam and Indonesia 





Between 2013 and 2018, the seizure of synthetic opioids in East and Southeast Asia 
have risen from three to 19 substances. Overdose consumption of synthetic opioids 
had caused deaths to the outside regions such as North America, Japan, and China. 
However, there is a lack of information regarding the seizure of synthetic opioids. This 
could be due to the substitution of heroin with synthetic opioids or adulteration of 
heroin with synthetic opioids to increase their profit (United Nations Office on Drugs 
and Crime, 2019a).  
 
Psychoactive plants including kratom and khat seizures were reported in East and 
Southeast Asia. These plants had been used on the local people, particularly in South 
East Asia for centuries, but they have recently been severely abused. Seizure of kratom 
plants was common in countries such as Malaysia, Myanmar, and Thailand. While, 
khat plant was reported in countries such as Cambodia, Hong Kong, China, Korea and 
Vietnam for the past two years (United Nations Office on Drugs and Crime, 2019a).  
 
Seizure of ketamine has been reduced since 2015 due to a decrease in the quantity of 
ketamine seizure in China. Seizure of ketamine in China decreased for more than 60% 
from 19.7 tons to 7.3 tons and 40% decrease in clandestine ketamine laboratories from 
97 to 54 between the year 2015 and 2017. However, the seizures of ketamine in 
Cambodia, Malaysia, Myanmar, and Thailand continue to increase in recent years. 
Manufacturing and trafficking cases of ketamine showed that Indian drug trafficking 
syndicates might have played the role in ketamine market in East and Southeast Asia. 




pseudoephedrine in Chennai, India where the illicit drug was about to traffic to 
Malaysia (United Nations Office on Drugs and Crime, 2019a).  
 
2.1.1.4 Ecstasy 
Smuggling and trafficking of ecstasy remain insignificant as compared to 
methamphetamine. Approximately 9 million ecstasy tablets were seized in East and 
Southeast Asia in 2017.  Countries such as Brunei Darussalam, Indonesia, Malaysia, 
and Singapore have recorded an increment in usage of ecstasy tablets (United Nations 
Office on Drugs and Crime, 2019a). However, it was noted that there is no country in 
East and Southeast Asia reported ecstasy as the top three most abused drugs, except 
Indonesia. Between 2013 and 2017, Indonesia has recorded an increase in the seizure 
of ecstasy with 40% followed by China 28% and Malaysia 14%. A case of trafficking 
1.2 million ecstasy tablets from the Netherlands was reported and seized in Indonesia 
(United Nations Office on Drugs and Crime, 2019b). In August 2018, 98 kg of ecstasy 
was seized by Cambodia authorities. This seizure was reported to the largest amount 
ever seized by the country. Philippines authorities also reported in seizing 14,720 
ecstasy tablets trafficked from France in 2017 (United Nations Office on Drugs and 
Crime, 2019a).   
 
The manufacture of ecstasy is not spread widely in East and Southeast Asia. Still, there 
are three countries including China, Malaysia, and Vietnam reported to have seized a 
number of ecstasy manufacturing facilities in 2017 (United Nations Office on Drugs 
and Crime, 2019b). During the seized of ecstasy manufacture facilities, Vietnam 
authorities reported in seizing 400 kg of ecstasy tablets, 85 kg of ecstasy powder and 




Content of methylenedioxy-methylamphetamine in ecstasy tablets varies within 
different countries. After all, Cambodia and Indonesia reported that nearly 50% 
methylenedioxy-methylamphetamine was used in the ecstasy tablets (United Nations 
Office on Drugs and Crime, 2019a).  
 
2.1.2 South Asia  
Trafficking of the drug in South Asia also had grown rapidly throughout the region, 
especially in the border areas of the sub-region. Among the drugs trafficked to South 
Asia are heroin, cannabis, methamphetamine, as well as pharmaceutical preparations 
containing narcotics and psychotropic substances. The trends of trafficking drugs 
showed that synthetic drugs are currently substituting or replacing natural and semi-
synthetic drugs (International Narcotics Control Board, 2019a). Moreover, the drug 
trafficking issue in South Asia had become challenging as there were one main drug 
producer and trafficker in the region, namely the Afghanistan. Besides, the coastal 
States of South Asia have a higher tendency to transport drug trafficking through 
maritime as they are exposed to trafficking routes across the India Ocean (International 
Narcotics Control Board, 2019a).  
 
2.1.2.1 Cannabis  
Cultivation of cannabis has become very challenging to law enforcement agencies in 
South Asia, especially India. Data from 2010 to 2017 showed that India was one of the 
countries that largely cultivated cannabis and produced cannabis. In 2018, Indian drug 
enforcement authorities had seized 1,980 hectors of illicit cannabis cultivation which 
was considerably less than 2017, reported at 3,446 hectors. While in Sri Lanka, an 




cannabis plants taken from 12 cultivation have been destroyed in Bhutan (International 
Narcotics Control Board, 2019a).  
 
The total of cannabis herb seized in 2018 had decreased to 336 tons as compared to 
the previous year with 434 tons. The largest quantities of cannabis herb seized in South 
Asia was in India with 266.5 tons or 79% of the total seizure, followed by Bangladesh 
with 60.3 tons or 18% of the total seizure. Other countries such as Bhutan, Nepal, and 
Sri Lanka reported with approximately 3% seizure amounted 9.1 tons. Seizure of 
cannabis resin in South Asia had increased from 3.2 tons in 2017 to 5.2 tons in 2018. 
The major countries that seized 100% or 5.2 tons of the cannabis resin were India and 
Nepal (International Narcotics Control Board, 2019a).  
 
2.1.3.2 Heroin  
Eradication of illicit opium poppy has increased over the four consecutive years since 
2015 in India. In 2018, 16 tons of poppy straw was seized in India, 70% greater than 
the total amount of poppy straw seized in 2017. Opium seizure in India had also 
increased with 1.7 tons, 2.3 tons, 2.6 tons and 4.1 tons between 2015 and 2018, 
respectively. The data seizure of opium and poppy straw showed that the problem of 
illicit opiates in South Asia was severe, affecting the general population (International 
Narcotics Control Board, 2019a).  
 
Seizure of heroin had increased in South Asia, especially Sri Lanka due to the 
expanding use of the southern route for trafficking drug. Majority of the heroin 
trafficked to South Asia crossed from Afghanistan to Pakistan and then to South Asia. 




to 732 kg in 2018 as compared to the previous year with 315 kg. However, it was noted 
that the seizure of heroin in South Asia had declined to 2.4 tons in 2018 from 2.9 tons 
in 2017. Countries that seized illicit heroin the most in South Asia was India with 1.2 
tons followed by Sri Lanka and Bangladesh with 0.7 tons and 0.45 tons, respectively 
(International Narcotics Control Board, 2019a).  
 
2.1.3.3 Methamphetamine  
South Asia is targeted by the Myanmar transnational organised criminal groups to the 
produce and traffic methamphetamine in South Asia. Methamphetamine is one of the 
abused drugs among the ATS in South Asia. Seizure of methamphetamine in South 
Asia was estimated to be 1% of the total seizure of methamphetamine at the global 
level. Methamphetamine seizure in Bangladesh continued to increase with an amount 
of 53 million tablets in 2018 and 40 million tablets in 2017. The increase was probably 
due to the nationwide anti-drug operation conducted by the Government. Besides, 
147.83 kg of methamphetamine were seized in the first quarter of 2019 (International 
Narcotics Control Board, 2019a).  
 
2.1.3 Africa  
Africa continues to encounter various challenges poses on drug trafficking and drug 
abuse. Sahel countries such as Mali, Mauritania and Niger showed an increasing 
volatility and insecurity due to increased drug trafficking from the south regions to the 
north region, mainly Libya (Shaw and Reitano, 2013). In the recent one quarter of a 
century, drug trafficking had been developed across Africa countries, especially 
Nigeria which acts as an intermediary for this illegal activity (Dorn et al., 2005). Data 
seizure in West Africa countries showed that these countries remain as the main transit 
